{"id":"NCT02477839","sponsor":"UCB BIOSCIENCES, Inc.","briefTitle":"Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects â‰¥1 Month to <4 Years With Partial-onset Seizures","officialTitle":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy >=1 Month to <4 Years of Age With Partial-Onset Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-05","primaryCompletion":"2020-05-28","completion":"2020-05-28","firstPosted":"2015-06-23","resultsPosted":"2021-07-01","lastUpdate":"2021-07-01"},"enrollment":255,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy With Partial-onset Seizures"],"interventions":[{"type":"DRUG","name":"Lacosamide","otherNames":["Vimpat","UCB Code: SPM 927","Abbreviated name: LCM"]},{"type":"OTHER","name":"Placebo","otherNames":["PBO"]}],"arms":[{"label":"Lacosamide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to assess the efficacy, safety and tolerability of lacosamide administered as add-on therapy with 1 to 3 anti-seizure medications. This trial is for children aged 1 month to less than 4 years with epilepsy who currently have uncontrolled partial-onset seizures.","primaryOutcome":{"measure":"Change in Average Daily Frequency (ADF) of Electrographic Partial-onset Seizures From End-of-Baseline (EOB) Period Video-EEG to End-of-Maintenance (EOM) Period Video-EEG","timeFrame":"End-of-Baseline Period (Day -3 to Day 1) to End-of-Maintenance Period (Day 24 to Day 27)","effectByArm":[{"arm":"Placebo (FAS)","deltaMin":1.44,"sd":0.06},{"arm":"Lacosamide (FAS)","deltaMin":1.4,"sd":0.06}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"=0.6895"}]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":13},"locations":{"siteCount":88,"countries":["United States","Argentina","Brazil","Bulgaria","China","Croatia","Czechia","France","Georgia","Greece","Hungary","Israel","Italy","Mexico","Moldova","Philippines","Poland","Portugal","Romania","Russia","Serbia","Slovakia","South Korea","Taiwan","Thailand","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":127},"commonTop":["Somnolence","Pyrexia","Upper respiratory tract infection","Irritability"]}}